Fabre Kramer Drug Patent Portfolio
Fabre Kramer owns 1 orange book drug protected by 1 US patent Given below is the list of Fabre Kramer's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7538116 | Treatment of sexual disorders | 02 Sep, 2025 | Active |
Latest Legal Activities on Fabre Kramer's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Fabre Kramer.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Second letter to regulating agency to determine regulatory review period | 14 Mar, 2024 | US7538116 |
| Letter from FDA or Dept of Agriculture re PTE application | 06 Feb, 2024 | US7538116 |
| Initial letter Re: PTE Application to regulating agency | 21 Nov, 2023 | US7538116 |
| Patent Term Extension Application under 35 USC 156 Filed | 16 Nov, 2023 | US7538116 |
| Payment of Maintenance Fee, 12th Yr, Small Entity | 25 Sep, 2020 | US7538116 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 05 Sep, 2019 | US7538116 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 26 May, 2009 | US7538116 |
|
Recordation of Patent Grant Mailed
Critical
| 26 May, 2009 | US7538116 |
|
Email Notification
Critical
| 07 May, 2009 | US7538116 |
|
Issue Notification Mailed
Critical
| 06 May, 2009 | US7538116 |
| Dispatch to FDC | 14 Apr, 2009 | US7538116 |
|
Application Is Considered Ready for Issue
Critical
| 14 Apr, 2009 | US7538116 |
|
Issue Fee Payment Received
Critical
| 13 Apr, 2009 | US7538116 |
|
Issue Fee Payment Verified
Critical
| 13 Apr, 2009 | US7538116 |
|
Mail Notice of Allowance
Critical
| 12 Jan, 2009 | US7538116 |
Fabre Kramer's Family Patents
Fabre Kramer Drug List
Given below is the complete list of Fabre Kramer's drugs and the patents protecting them.
1. Exxua
Exxua is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7538116 | Treatment of sexual disorders |
02 Sep, 2025
(10 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Exxua's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List